234 related articles for article (PubMed ID: 31177553)
1. Implementation of an NGS-based sequencing and gene fusion panel for clinical screening of patients with suspected hematologic malignancies.
Levy MA; Santos S; Kerkhof J; Stuart A; Aref-Eshghi E; Guo F; Hedley B; Wong H; Rauh M; Feilotter H; Berardi P; Semenuk L; Yang P; Knoll J; Ainsworth P; McLachlin CM; Chin-Yee I; Kovacs M; Deotare U; Lazo-Langner A; Hsia C; Keeney M; Xenocostas A; Howlett C; Lin H; Sadikovic B
Eur J Haematol; 2019 Sep; 103(3):178-189. PubMed ID: 31177553
[TBL] [Abstract][Full Text] [Related]
2. Diagnostic Validation of a Clinical Laboratory-Oriented Targeted RNA Sequencing System for Detecting Gene Fusions in Hematologic Malignancies.
Lim HJ; Lee JH; Lee SY; Choi HW; Choi HJ; Kee SJ; Shin JH; Shin MG
J Mol Diagn; 2021 Aug; 23(8):1015-1029. PubMed ID: 34082071
[TBL] [Abstract][Full Text] [Related]
3. A multimodal genomics approach to diagnostic evaluation of pediatric hematologic malignancies.
Hiemenz MC; Oberley MJ; Doan A; Aye L; Ji J; Schmidt RJ; Biegel JA; Bhojwani D; Raca G
Cancer Genet; 2021 Jun; 254-255():25-33. PubMed ID: 33571894
[TBL] [Abstract][Full Text] [Related]
4. Integration of Technical, Bioinformatic, and Variant Assessment Approaches in the Validation of a Targeted Next-Generation Sequencing Panel for Myeloid Malignancies.
Thomas M; Sukhai MA; Zhang T; Dolatshahi R; Harbi D; Garg S; Misyura M; Pugh T; Stockley TL; Kamel-Reid S
Arch Pathol Lab Med; 2017 Jun; 141(6):759-775. PubMed ID: 28557600
[TBL] [Abstract][Full Text] [Related]
5. Principles of analytical validation of next-generation sequencing based mutational analysis for hematologic neoplasms in a CLIA-certified laboratory.
Kanagal-Shamanna R; Singh RR; Routbort MJ; Patel KP; Medeiros LJ; Luthra R
Expert Rev Mol Diagn; 2016; 16(4):461-72. PubMed ID: 26765348
[TBL] [Abstract][Full Text] [Related]
6. Clinical utility of target capture-based panel sequencing in hematological malignancies: A multicenter feasibility study.
Yasuda T; Sanada M; Nishijima D; Kanamori T; Iijima Y; Hattori H; Saito A; Miyoshi H; Ishikawa Y; Asou N; Usuki K; Hirabayashi S; Kato M; Ri M; Handa H; Ishida T; Shibayama H; Abe M; Iriyama C; Karube K; Nishikori M; Ohshima K; Kataoka K; Yoshida K; Shiraishi Y; Goto H; Adachi S; Kobayashi R; Kiyoi H; Miyazaki Y; Ogawa S; Kurahashi H; Yokoyama H; Manabe A; Iida S; Tomita A; Horibe K
Cancer Sci; 2020 Sep; 111(9):3367-3378. PubMed ID: 32619037
[TBL] [Abstract][Full Text] [Related]
7. Improving the detection of patients with inherited predispositions to hematologic malignancies using next-generation sequencing-based leukemia prognostication panels.
DiNardo CD; Routbort MJ; Bannon SA; Benton CB; Takahashi K; Kornblau SM; Luthra R; Kanagal-Shamanna R; Medeiros LJ; Garcia-Manero G; M Kantarjian H; Futreal PA; Meric-Bernstam F; Patel KP
Cancer; 2018 Jul; 124(13):2704-2713. PubMed ID: 29682723
[TBL] [Abstract][Full Text] [Related]
8. Development and analytical validation of a 25-gene next generation sequencing panel that includes the BRCA1 and BRCA2 genes to assess hereditary cancer risk.
Judkins T; Leclair B; Bowles K; Gutin N; Trost J; McCulloch J; Bhatnagar S; Murray A; Craft J; Wardell B; Bastian M; Mitchell J; Chen J; Tran T; Williams D; Potter J; Jammulapati S; Perry M; Morris B; Roa B; Timms K
BMC Cancer; 2015 Apr; 15():215. PubMed ID: 25886519
[TBL] [Abstract][Full Text] [Related]
9. Korean Society for Genetic Diagnostics Guidelines for Validation of Next-Generation Sequencing-Based Somatic Variant Detection in Hematologic Malignancies.
Kim H; Yun JW; Lee ST; Kim HJ; Kim SH; Kim JW;
Ann Lab Med; 2019 Nov; 39(6):515-523. PubMed ID: 31240878
[TBL] [Abstract][Full Text] [Related]
10. Detection of leukemia gene fusions by targeted RNA-sequencing in routine diagnostics.
Engvall M; Cahill N; Jonsson BI; Höglund M; Hallböök H; Cavelier L
BMC Med Genomics; 2020 Jul; 13(1):106. PubMed ID: 32727569
[TBL] [Abstract][Full Text] [Related]
11. The Value of Next-Generation Sequencing in the Screening and Evaluation of Hematologic Neoplasms in Clinical Practice.
Northrup V; Maybank A; Carson N; Rahmeh T
Am J Clin Pathol; 2020 Apr; 153(5):639-645. PubMed ID: 31875888
[TBL] [Abstract][Full Text] [Related]
12. LYmphoid NeXt-Generation Sequencing (LYNX) Panel: A Comprehensive Capture-Based Sequencing Tool for the Analysis of Prognostic and Predictive Markers in Lymphoid Malignancies.
Navrkalova V; Plevova K; Hynst J; Pal K; Mareckova A; Reigl T; Jelinkova H; Vrzalova Z; Stranska K; Pavlova S; Panovska A; Janikova A; Doubek M; Kotaskova J; Pospisilova S
J Mol Diagn; 2021 Aug; 23(8):959-974. PubMed ID: 34082072
[TBL] [Abstract][Full Text] [Related]
13. Molecular Pathology: Prognostic and Diagnostic Genomic Markers for Myeloid Neoplasms.
Kuo FC
Surg Pathol Clin; 2016 Sep; 9(3):475-88. PubMed ID: 27523973
[TBL] [Abstract][Full Text] [Related]
14. Genomic testing in myeloid malignancy.
Docking TR; Karsan A
Int J Lab Hematol; 2019 May; 41 Suppl 1():117-125. PubMed ID: 31069982
[TBL] [Abstract][Full Text] [Related]
15. Validation and Implementation of a Custom Next-Generation Sequencing Clinical Assay for Hematologic Malignancies.
Kluk MJ; Lindsley RC; Aster JC; Lindeman NI; Szeto D; Hall D; Kuo FC
J Mol Diagn; 2016 Jul; 18(4):507-15. PubMed ID: 27339098
[TBL] [Abstract][Full Text] [Related]
16. Next-generation sequencing-based panel testing for myeloid neoplasms.
Kuo FC; Dong F
Curr Hematol Malig Rep; 2015 Jun; 10(2):104-11. PubMed ID: 25933675
[TBL] [Abstract][Full Text] [Related]
17. [NGS-based multi-gene panel testing in hematological malignancies: therapeutic significance].
Maeda T
Rinsho Ketsueki; 2022; 63(4):302-307. PubMed ID: 35491220
[TBL] [Abstract][Full Text] [Related]
18. Clinical evaluation of panel testing by next-generation sequencing (NGS) for gene mutations in myeloid neoplasms.
Au CH; Wa A; Ho DN; Chan TL; Ma ES
Diagn Pathol; 2016 Jan; 11():11. PubMed ID: 26796102
[TBL] [Abstract][Full Text] [Related]
19. Validation of the Oncomine
Williams HL; Walsh K; Diamond A; Oniscu A; Deans ZC
Virchows Arch; 2018 Oct; 473(4):489-503. PubMed ID: 30105577
[TBL] [Abstract][Full Text] [Related]
20. A Targeted High-Throughput Next-Generation Sequencing Panel for Clinical Screening of Mutations, Gene Amplifications, and Fusions in Solid Tumors.
Luthra R; Patel KP; Routbort MJ; Broaddus RR; Yau J; Simien C; Chen W; Hatfield DZ; Medeiros LJ; Singh RR
J Mol Diagn; 2017 Mar; 19(2):255-264. PubMed ID: 28017569
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
